Search Results for "Congestive Hepatopathy"
Original Source: Predictors of cardiac hepatopathy in patients with right heart failure.
Background: Some patients with right heart failure develop cardiac hepatopathy (CH). The pathophysiology of CH is thought to be secondary to hepatic venous congestion and arterial ischemia. We sought to define the clinical and hemodynamic characteristics associated with CH. Material/Methods: A retrospective cross sectional analysis was performed in which subjects were identified from our institutional cardiology database if echocardiography showed either right ventricular (RV) hypokinesis or dilatation, a...
Matching Channels
Matching News
Congestive heart failure patients may benefit from a test for pulmonary hypertension
(Medical Xpress) -- A new Emory University study highlights the importance of performing an echocardiogram to measure pulmonary artery systolic pressures in stable patients with congestive heart failu...
Trastuzumab Increases Congestive Heart Failure Risk
Breast cancer patients treated with trastuzumab chemotherapy are at an increased risk for heart failure and/or cardiomyopathy (HF/CM) compared to women not treated with chemotherapy, according to a st...
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases, today announces...
Trastuzumab Increases risk of congestive heart failure
The $5 Billion Opportunity For Sunshine Heart's C-Pulse Device
By Adam Sans:The case of Heartware (HTWR) and by extension, LVADs, is an indicator of how efficacious medical devices in late-stage CHF can be quite lucrative for a patient class with little by way of...
Cytokinetics: Key Issues For Beginning Phase III For Omecamtiv Mecarbil In Congestive Heart Failure
By Smith On Stocks: Overview and Investment Importance Those who read my initiation report on Cytokinetics (CYTK) understand that the importance of successfully conducting a phase III trial for omec...
Sunshine Heart Quietly Reports Breakthrough In Congestive Heart Failure Treatment
ByLogical Assessment: Revisiting Sunshine Heart Sunshine Heart (SSH) is a development stage company looking to establish a position within the $37 billion Congestive Heart Failure (CHF) market with...
BREAKING NEWS: FDA Panel Say No on Lixavaptan
WASHINGTON (MedPage Today) -- An FDA advisory panel has voted unanimously against recommending approval of lixivaptan (Lixar) for treatment of hyponatremia in congestive heart failure and 3-5 against...
Matching PubMed Articles
Predictors of cardiac hepatopathy in patients with right heart failure.
Background: Some patients with right heart failure develop cardiac hepatopathy (CH). The pathophysiology of CH is thought to be secondary to hepatic venous congestion and arterial ischemia. We sought...
Glycogen hepatopathy in a 13-year-old male with type 1 diabetes.
Glycogenic hepatopathy (GH ) is a rare cause of serum transaminase elevations in type 1 diabetes mellitus. We describe a 13-year-old male with a history of poorly controlled type 1 diabetes mellitus w...
Chronic Budd-Chiari syndrome can cause liver cirrhosis.
Budd-Chiari syndrome (BCS) is a rare disease defined by congestive hepatopathy with obstruction of the hepatic venous outflow tract. Classical symptoms and signs include ascites, hepatomegaly, abdomin...
Disposition of ceftriaxone in hepatopathic goats following single-intramuscular dosing.
Hepatopathy sometimes may interfere with metabolism and/or elimination of drugs which undergo major hepatic clearance. Twelve healthy goats were equally divided into two groups (I and II) and hepatopa...
Endothelin-1 levels in chronic congestive heart failure.
BACKGROUND: Endothelin-1 levels in patients with chronic congestive heart failure were evaluated with respect to the severity of cardiac dysfunction. The relationships between three neurohormones, bra...
